Literature DB >> 8241126

Use of nitrogen-15 kinetic isotope effects to elucidate details of the chemical mechanism of human immunodeficiency virus 1 protease.

E J Rodriguez1, T S Angeles, T D Meek.   

Abstract

We have used 15N kinetic isotope effects of the HIV-1 protease-catalyzed peptidolysis of Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2 to characterize the chemical mechanism of this enzyme. In addition, the multiple isotope effects have been determined by measuring the 15N kinetic isotope effects in both H2O and D2O. The isotope effects, measured on values of V/K, were determined by the incorporation of a radiolabel (tritium and 14C in peptides bearing the heavy and light isotopes, respectively) at a position remote from the isotopically labeled scissile peptide bond, such that the isotope effect was determined by measurement of the change in the 14C/3H ratio in recovered substrates at various fractions of reaction. At pH = 6.0 (37 degrees C), the nitrogen isotope effects were slightly, but significantly, inverse in both solvents: 15(V/K)H2O = 0.995 +/- 0.002, and 15(V/K)D2O = 0.992 +/- 0.003. The observation of an inverse nitrogen kinetic isotope effect implies that bonding to the nitrogen atom is becoming stiffened in a reaction transition state, and since this inverse isotope effect is enhanced in D2O, this isotope effect likely arises from protonation of the proline nitrogen atom.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8241126     DOI: 10.1021/bi00097a015

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  The role of hydrogen bonding in the enzymatic reaction catalyzed by HIV-1 protease.

Authors:  Joanna Trylska; Pawel Grochowski; J Andrew McCammon
Journal:  Protein Sci       Date:  2004-02       Impact factor: 6.725

2.  Transition states of native and drug-resistant HIV-1 protease are the same.

Authors:  D Randal Kipp; Jennifer S Hirschi; Aya Wakata; Harris Goldstein; Vern L Schramm
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-09       Impact factor: 11.205

3.  Validating the vitality strategy for fighting drug resistance.

Authors:  Nidhi Singh; Maria P Frushicheva; Arieh Warshel
Journal:  Proteins       Date:  2012-01-31

4.  Crystal structure of HIV-1 protease in situ product complex and observation of a low-barrier hydrogen bond between catalytic aspartates.

Authors:  Amit Das; Vishal Prashar; Smita Mahale; L Serre; J-L Ferrer; M V Hosur
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-20       Impact factor: 11.205

5.  Effect of the active site D25N mutation on the structure, stability, and ligand binding of the mature HIV-1 protease.

Authors:  Jane M Sayer; Fengling Liu; Rieko Ishima; Irene T Weber; John M Louis
Journal:  J Biol Chem       Date:  2008-02-15       Impact factor: 5.157

6.  Dynamic and Electrostatic Effects on the Reaction Catalyzed by HIV-1 Protease.

Authors:  Agnieszka Krzemińska; Vicent Moliner; Katarzyna Świderek
Journal:  J Am Chem Soc       Date:  2016-12-09       Impact factor: 15.419

7.  Ab initio molecular dynamics studies on HIV-1 reverse transcriptase triphosphate binding site: implications for nucleoside-analog drug resistance.

Authors:  F Alber; P Carloni
Journal:  Protein Sci       Date:  2000-12       Impact factor: 6.725

8.  Molecular dynamics simulations of the first steps of the reaction catalyzed by HIV-1 protease.

Authors:  Joanna Trylska; Piotr Bała; Maciej Geller; Paweł Grochowski
Journal:  Biophys J       Date:  2002-08       Impact factor: 4.033

9.  Using the Relative Energy Gradient Method with Interacting Quantum Atoms to Determine the Reaction Mechanism and Catalytic Effects in the Peptide Hydrolysis in HIV-1 Protease.

Authors:  Joseph C R Thacker; Mark A Vincent; Paul L A Popelier
Journal:  Chemistry       Date:  2018-07-03       Impact factor: 5.236

10.  Visualizing Tetrahedral Oxyanion Bound in HIV-1 Protease Using Neutrons: Implications for the Catalytic Mechanism and Drug Design.

Authors:  Mukesh Kumar; Kalyaneswar Mandal; Matthew P Blakeley; Troy Wymore; Stephen B H Kent; John M Louis; Amit Das; Andrey Kovalevsky
Journal:  ACS Omega       Date:  2020-05-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.